Article Information
History
- April 13, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marte Sneeggen1,2,
- Nina Marie Pedersen1,2,
- Coen Campsteijn3,
- Ellen Margrethe Haugsten1,4,
- Harald Stenmark1,2,∗ and
- Kay Oliver Schink1,2,∗
- 1Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Montebello, N-0379 Oslo, Norway.
- 2Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, N-0379 Oslo, Norway
- 3Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, 0317 Oslo, Norway
- 4Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, N-0379 Oslo, Norway
- ↵∗Corresponding authors : Dr. Harald Stenmark Department of Molecular Cell Biology Institute for Cancer Research Oslo University Hospital, Montebello 0379 Oslo Norway h.a.stenmark{at}medisin.uio.no +47 22781818 Dr. Kay Oliver Schink Department of Molecular Cell Biology Institute for Cancer Research Oslo University Hospital, Montebello 0379 Oslo Norway Kay.Oliver.Schink{at}rr-research.no +47 22781809